Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
INCB-123667 by Incyte for Triple-Negative Breast Cancer (TNBC): Likelihood of Approval
INCB-123667 is under clinical development by Incyte and currently in Phase I for Triple-Negative Breast Cancer (TNBC). According to GlobalData,...
INCB-123667 by Incyte for Epithelial Ovarian Cancer: Likelihood of Approval
INCB-123667 is under clinical development by Incyte and currently in Phase I for Epithelial Ovarian Cancer. According to GlobalData, Phase...
INCB-123667 by Incyte for Peritoneal Cancer: Likelihood of Approval
INCB-123667 is under clinical development by Incyte and currently in Phase I for Peritoneal Cancer. According to GlobalData, Phase I...
INCB-123667 by Incyte for Fallopian Tube Cancer: Likelihood of Approval
INCB-123667 is under clinical development by Incyte and currently in Phase I for Fallopian Tube Cancer. According to GlobalData, Phase...